Shuanglv Fensuan Nashuan (双氯芬酸钠栓)双氯芬酸钠栓

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

双氯芬酸钠是一种在国家药监局注册认定的药品。该药品含有双氯芬酸钠-823eb766等成分。

该药品关联的活性成分包括:双氯芬酸钠Shuanglv Fensuan Na。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:湖北炎黄本草药业有限公司Chinese legal name: 湖北炎黄本草药业有限公司。

您可以探索含有相同成分的其他药品:双氯芬酸钠-823eb766成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 双氯芬酸钠栓) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 双氯芬酸钠Shuanglv Fensuan Na.

Manufacturers recorded for this product: 湖北炎黄本草药业有限公司Chinese legal name: 湖北炎黄本草药业有限公司.

Explore other medicines containing the same ingredient: 双氯芬酸钠 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 双氯芬酸钠栓Recorded Chinese name: 双氯芬酸钠栓
  • 规格Specification: 50mg50 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 湖北炎黄本草药业有限公司Chinese legal name: 湖北炎黄本草药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H42020485

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H42020485

Manufacturer

Chinese legal name: 湖北炎黄本草药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H42020485

生产企业

湖北炎黄本草药业有限公司(国产)

适应症

本品用于类风湿性关节炎,手术后疼痛及各种原因所致的发热。

用法用量

用时将栓剂取出,以少量温水湿润后,轻轻塞入肛门2cm处,成人一次50mg,一日50mg~100mg,或遵医嘱。

不良反应

1. 胃肠反应:主要为肛门刺激症状、胃不适、烧灼感、反酸、纳差、恶心等,停药或对症处理即可消失。其中少数可出现溃疡、出血、穿孔。2. 神经系统表现有头痛、眩晕、嗜睡、兴奋等。3. 肾脏引起浮肿、少尿、电解质紊乱等严重肾不良反应。4. 其他少见的有肝酶一过性升高,极个别出现黄疸、皮疹、心律失常、粒细胞减少、血小板减少等均呈可逆性。

禁忌

对患者有严重肝、肾功能不全及高过敏体质者禁用,儿童慎用。对阿司匹林或其他非甾体消炎药过敏者对本品可有交叉过敏反应。对阿司匹林过敏的哮喘患者,本品也可引起支气管痉挛,对这类患者禁用。有肛门炎症者禁用。

注意事项

1. 有肝、肾功能损害或溃疡病史者慎用,尤其是老年人。用药期间应常规随访检查肝肾功能。 2. 本品因含钠,对限制钠摄入量的病人应慎用。3. 对诊断的干扰:本品可致血清肝酶一过性升高,血清尿酸含量下降,尿尿酸含量升高(因肾清除功能增高)。

贮藏

遮光,密闭,在30℃以下保存。

规格

50mg

证据Evidence

  • 批准文号: 国药准字H42020485
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.